1-14 of 14
Andrea Kerkhoff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG

Gerhard Held, Bettina Altmann, Andrea Kerkhoff, Thomas Gastinne, Thomas Weber, Rene-Olivier Casasnovas, Hervé Tilly, Maria Gomes Da Silva, Jörg Hoffmann, Sanne Tonino, Stéphane Vigouroux, Martin Dreyling, Violaine Safar, Marc Andre, Stephanie Mayer, Franck Morschhauser, Pierre Feugier, Christian W. Scholz, Anna Dabrowska-Iwanicka, Philippe Gaulard, Thierry Jo Molina, Andreas Rosenwald, Richard Greil, Ulrich Jaeger, Abraham Avigdor, Lorenz Thurner, Stephanie Maurer, Markus Löffler, Marita Ziepert, Corinne Haioun, Viola Poeschel, Roch Houot
Journal: Blood
Blood (2023) 142 (Supplement 1): 435.
https://doi.org/10.1182/blood-2023-172951
Published: 2023
Journal Articles

Pregnancies and Childbirth Following Advanced-Stage Hodgkin Lymphoma Treatment with Brecadd or Beacopp in the Randomized Phase III GHSG HD21 Trial

Justin Ferdinandus, Gundolf Schneider, Alexander Fosså, Alden Moccia, Richard Greil, Mark S. Hertzberg, Josée M. Zijlstra, Peter Kamper, Daniel L. Molin, Andrea Kerkhoff, Sebastian Scholl, Yon-Dschun Ko, Max S. Topp, Joachim Beck, Vladan Vucinic, Wolfram Jung, Roland Schroers, Andreas Rank, Carla Damaschin, Anne Sophie Jacob, Michael Fuchs, Peter Borchmann, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4437.
https://doi.org/10.1182/blood-2023-188449
Published: 2023
Journal Articles

Real World Results of Brexucabtagene Autoleucel for Patients with Relapsed/Refractory Mantle Cell Lymphoma - First German/Swiss Analysis

Georg Hess, Vladan Vucinic, Kai Rejeski, Enver Aydilek, Linda Simon, Olaf Penack, Christian Koenecke, Malte von Bonin, Bastian von Tresckow, Martin Fehr, Christiane Pott, Stephan Stilgenbauer, Corinna Leng, Roland Schroers, Johannes Duell, Reinhard Marks, Fabian Mueller, Uta Brunnberg, Andrea Kerkhoff, Anke Ohler, Eva-Maria Wagner Drouet, Irene Schmidtmann, Matthias Theobald, Martin Dreyling, Peter Dreger
Journal: Blood
Blood (2023) 142 (Supplement 1): 4394.
https://doi.org/10.1182/blood-2023-182415
Published: 2023
Journal Articles

Tafasitamab and Lenalidomide in Relapsed/Refractory B-Cell Lymphoma: A Multicenter Retrospective Real-World-Study of Patients from Germany and Austria

Anna Ruckdeschel, Koemm Sabrina, Max S. Topp, Richard Greil, Thomas Melchardt, Georg Lenz, Andrea Kerkhoff, Evgenii Shumilov, Georg Hess, Marta Baumgaertner, Lorenz Thurner, Igor Age Kos, Stephanie Mayer, Francis A. Ayuk, Rolf Krause, Marco Herling, Vladan Vucinic, Claudia Chapuy, Gerald Illerhaus, Markus Knott, Andreas Viardot, Alexander Grunenberg, Sascha Dietrich, Leandra Caille, Mareike C. Tometten, Hyunyee Rosa Cho, Julia Scholz, Fabian Mueller, Katharina Prochazka, Bjoern Chapuy, David Böckle, Bastian von Tresckow, Natalie Schub, Götz Gelbrich, Hermann Einsele, Johannes Duell
Journal: Blood
Blood (2023) 142 (Supplement 1): 1771.
https://doi.org/10.1182/blood-2023-185992
Published: 2023
Journal Articles

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Elisabeth Schorb, Lisa Isbell, Andrea Kerkhoff, Stephan Mathas, Friederike Braulke, Gerlinde Egerer, Alexander Roeth, Simon Christian Schliffke, Peter Borchmann, Uta Brunnberg, Frank P. Kroschinsky, Robert Möhle, Andreas Rank, Dominique Wellnitz, Benjamin Kasenda, Lisa Pospiech, Julia Wendler, Gabriele Ihorst, Florian Scherer, Martina Deckert, Elina Henkes, Justus Duyster, Jürgen Finke, Gerald Illerhaus
Journal: Blood
Blood (2022) 140 (Supplement 1): 1773–1774.
https://doi.org/10.1182/blood-2022-162157
Published: 2022
Journal Articles

Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann-Grill, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Journal: Blood
Blood (2022) 140 (Supplement 1): 1753–1755.
https://doi.org/10.1182/blood-2022-168846
Published: 2022
Journal Articles

Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL)

Daniela V. Wenge, Klaus Wethmar, Corinna Klar, Hedwig Kolve, Tim Sauer, Linus Angenendt, Georg Evers, Simon Call, Andrea Kerkhoff, Cyrus Khandanpour, Torsten Kessler, Rolf M. Mesters, Christoph Schliemann, Jan-Henrik Mikesch, Christian Reicherts, Monika Brüggemann, Wolfgang E. Berdel, Georg Lenz, Matthias Stelljes
Journal: Blood
Blood (2021) 138 (Supplement 1): 3365.
https://doi.org/10.1182/blood-2021-146459
Published: 2021
Journal Articles

Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

Paul J Bröckelmann, MD, Helen Goergen, Dipl.-Math., Ulrich Keller, Julia Meissner, MD, Karolin Trautmann, MD, Teresa V Halbsguth, MD, Stephanie Sasse, MD, Martin Sökler, MD, Andrea Kerkhoff, MD, Stephan Mathas, MD, Andreas Hüttmann, MD, Matthias Bormann, MD, Andreas Zimmermann, MD, Michael Fuchs, Bastian von Tresckow, MD, Christian Baues, MD, Andreas Rosenwald, MD, Wolfram Klapper, MD, Carsten Kobe, MD, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-138413
Published: 2020
Journal Articles

Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (CUP)

Nora Liebers, MD, Johannes Duell, MD, Daniel Nörenberg, MD, Eva Kaebisch, MD, Andrea Kerkhoff, MD, Fabian Acker, MD, Stephan Fuhrmann, MD, Corinna Leng, MD PhD, Manfred Welslau, MD, Jens Chemnitz, MD, Jan Moritz Middeke, MD, Thomas Weber, MD, Ralf Ulrich Trappe, MD, Roald Pfannes, MD, Ruediger Liersch, MD, Christian Spoer, MD, Niklas Gebauer, MD, Stefan Fuxius, MD, Léandra Caillé, Christiane Pott, MD PhD, Christian Koenecke, MD, Udo Holtick, Thomas Geer, MD, Ulrich Keller, MD, Rainer Claus, MD, Dimitrios Mougiakakos, MD, Stephanie Mayer, MD, Andreas Hüttmann, MD, Arne Trummer, MD, Gerald Wulf, MD, Uta Brunnberg, MD, Lars Bullinger, MD, Georg Hess, MD, Carsten Mueller-Tidow, MD, Bertram Glass, MD, Georg Lenz, Peter Dreger, MD, Sascha Dietrich, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-136539
Published: 2020
Journal Articles

Pre-Planned Interim Safety Analysis of the Niveau Trial, a Randomized Phase 3 Study for Patients with Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivolumab in Combination with Gemcitabine, Oxaliplatin (GemOx) Plus Rituximab (R) in Case of B-Cell Lymphoma

Lorenz Thurner, MD, Viola Poeschel, MD, Bettina Altmann, PhD, Herve Tilly, MD PhD, Marc Andre, MD, Marie Maerevoet, MD, Thomas Weber, MD, Joerg Hoffmann, MD, Martin Dreyling, MD, Herve Maisonneuve, MD, Andrea Kerkhoff, MD, Steven Le Gouill, MD PhD, Stephan Stilgenbauer, MD, Marita Ziepert, PhD, Roch Houot, MDPhD, Corinne Haioun, MDPhD, Gerhard Held, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32.
https://doi.org/10.1182/blood-2020-139459
Published: 2020
Journal Articles

Nivolumab in Combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-Cell Lymphoma: Preliminary Results of the Experimental Arm of the Niveau Trial

Roch Houot, MDPhD, Viola Poeschel, MD, Bettina Altmann, PhD, Thomas Illmer, MD, Marc André, MD, Martin Dreyling, MD, Herve Maisonneuve, MD, Herve Tilly, MD PhD, Stephanie Mayer, MD, Rene-Olivier Casasnovas, MD, Steven Le Gouill, MD PhD, Fritz C. Offner, MD PhD, Guillaume Cartron, MD PhD, Andrea Kerkhoff, MD, Thomas Weber, MD, Joerg Hoffmann, MD, Marita Ziepert, PhD, Wolfram Klapper, MD, Emmanuel Itti, MD PhD, Dirk Hellwig, Laurence De Leval, MD, Andreas Rosenwald, MD, Corinne Haioun, MD PhD, Laurent Dercle, MD, Philippe Gaulard, MD PhD, Gerhard Held, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-136941
Published: 2020
Journal Articles

Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)

Paul J Bröckelmann, MD, Helen Goergen, Dipl.-Math., Ulrich Keller, MD, Julia Meissner, MD, Rainer Ordemann, MD, Teresa V Halbsguth, MD, Stephanie Sasse, MD, Martin Sökler, MD, Andrea Kerkhoff, MD, Stephan Mathas, MD, Andreas Hüttmann, MD, Matthias Bormann, MD, Andreas Zimmermann, MD, Michael Fuchs, MD, Bastian von Tresckow, Christian Baues, MD, Andreas Rosenwald, MD, Wolfram Klapper, Carsten Kobe, Peter Borchmann, MD PhD, Andreas Engert, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 236.
https://doi.org/10.1182/blood-2019-122406
Published: 2019
Journal Articles

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials

Clinical Trials & Observations Brief Report
Boris Böll, Helen Goergen, Karolin Behringer, Paul J. Bröckelmann, Felicitas Hitz, Andrea Kerkhoff, Richard Greil, Bastian von Tresckow, Dennis A. Eichenauer, Carolin Bürkle, Sven Borchmann, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2016) 127 (18): 2189–2192.
https://doi.org/10.1182/blood-2015-11-681064
Published: 2016
Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 980.
https://doi.org/10.1182/blood.V124.21.980.980
Published: 2014